---
title: Laurus Labs vs Rentschler Biopharma SE
slug_a: lauruslabs
slug_b: rentschler-biopharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/lauruslabs/rentschler-biopharma
---

# Laurus Labs vs Rentschler Biopharma SE

Side-by-side profile data from each company listing on this directory.

## Laurus Labs

- Profile: [/companies/lauruslabs](/companies/lauruslabs)

Laurus Labs — Global pharmaceutical company specializing in APIs, formulations, and CDMO services for small molecule and biologics.

Services: 7. Modalities: 2. Indications: 0. Locations: 0. Certifications: 1. The strongest documented coverage currently appears in services (7).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Other)

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Rentschler Biopharma SE

- Profile: [/companies/rentschler-biopharma](/companies/rentschler-biopharma)

Rentschler Biopharma SE — Rentschler Biopharma is a family-owned CDMO offering bioprocess development and manufacturing of biopharmaceuticals, with about 50 years of experience. It operates sites in Laupheim, Germany and Milford, Massachusetts, USA.

Services: 8. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Regulatory Affairs
- Analytical Method Development & Validation
- Biologics Development & Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Biologics (Other)

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Data not yet provided.